Regular physical exercise (PE) leads to a systemic adaptation to redox homeostasis perturbation, one of the hallmarks of exercise adaptation. Studies have shown that PE can alter the molecular composition of extracellular vesicles (EVs), impacting their ability to communicate with other cells and modulate physiological processes. EVs circulating in the body and secreted from various cell types, including skeletal muscle cells, contain various regulatory molecules and mediate intercellular communications and tissue cross-talk. Considering that the health-related benefits of a physically active lifestyle are partially driven by various bioactive molecules released into the circulation during exercise, collectively termed “exerkines”, there has been a rapidly growing interest in the role of EVs cargo as “carriers” in the multi-systemic, adaptive response to exercise. Indeed, a potential mechanism by which plasma EVs released during exercise impact ageing and diseases related to redox impairment is increased delivery of redox components, such as redox transcription factors and antioxidants. This presentation will offer a general overview of the biology of exercise-induced EVs and their putative role in health maintenance and disease prevention, with a focus on redox homeostasis control.  

Dysregulation of the redox system and the interconnected low-level inflammation (LLI) act as a driving force of damaging mechanisms in gestational diabetes mellitus (GDM) and are strongly related to severe obstetric and neonatal complications of hyperglycaemic pregnancies. Major disturbances in microRNA-based mechanism accompany (glyco)oxidative stress ((g)OS), for which reason we hypothesized that microRNAs may serve as sensors and/or effectors of (g)OS/LLI in GDM and we chose candidates for GDM biomarker analysis among known (g)OS/LLI-associated microRNAs. The aim of the study was to analyze the properties of miR-146a-5p and miR-21-5p as redox status indicators in GDM, as well as to compare two different biological samples as sources of potentially relevant GDM biomarkers.  miR-146a-5p and miR-21-5p were quantified by real-time polymerase chain reaction in peripheral blood mononuclear cells of patients with GDM and normoglycaemic pregnant controls (n=40 each), as well as in paired samples of extracellular vesicles (EVs) extracted from serum. Correlation analysis was conducted for the expression levels of tested microRNAs and the activities of glutathione reductase (GR), total superoxide dismutase (SOD), catalase (CAT), concentration of serum thiol groups and the level of Nrf2 mRNA. In both samples, tested microRNAs were upregulated in GDM group, with a more pronounced increase in expression in EVs, compared to peripheral blood mononuclear cells (PBMCs) (1.81 vs. 1.52 fold for miR-146a-5p and 1.98 vs. 1.58 fold for miR-21-5p). There was a significant positive correlation between the expression of miR-21-5p from PBMCs and Nrf2 in both GDM patients and controls, as well as a positive correlation with the activity of total SOD in GDM patients. On the other hand, miR-146a-5p from EVs demonstrated negative correlation with Nrf2 expression and the activity of total SOD. These data demonstrate the potential of (g)OS/LLI-related microRNAs miR-146a-5p and miR-21-5p to serve as indicators of GDM and the associated (g)OS-related changes.

According to global epidemiology, non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, affecting about a quarter of the adult population worldwide. NAFLD is characterised by the accumulation of triglycerides in hepatocytes (steatosis), which can progress to non-alcoholic steatohepatitis, a more severe form of NAFLD. Oxidative stress is closely linked to the disease progression due to the activation of inflammatory pathways. The aim of this study was to identify markers of redox status that could predict the risk of developing steatosis. The study included 179 participants who underwent ultrasound examination at University Medical Centers Zemun and Zvezdara. Participants were divided into two groups: 119 patients with steatosis and 60 apparently healthy controls (control group, CG). Biochemical markers as well as markers of redox status: total oxidant status (TOS) and total antioxidant status (TAS) were determined in serum spectrophotometrically on biochemical analysers. Univariate and multivariate binary logistic regression analyses were used to test the predictions of TOS and TAS for NAFLD. Patients had higher body mass index (P<0.001), glucose (P<0.001), uric acid (P<0.001), TOS (P=0.007), and TAS (P<0.001) levels compared to CG. Univariate binary regression analysis revealed significant predictive capability of TOS and TAS for NAFLD demonstrated by the following ORs: 1.104 (1.020-1.195) (P=0.014) and 1.003 (1.001-1.004) (P<0.001), respectively. After applying multivariate binary logistic regression analyses (adjustments were made for sex and BMI), TOS and TAS kept independent significant predictive capability for NAFLD, as demonstrated by the following ORs: 1.098 (1.009-1.195) (P=0.030) and 1.002 (1.000-1.003) (P=0.026), respectively. TOS and TAS are positively associated with the risk of developing NAFLD, independent of sex and BMI. Both markers are elevated, probably because increased oxidative activity requires a stronger antioxidant defence response, which should be confirmed by a follow-up study including more participants.